The European Medicines Agency has listed the neurological disorder Guillain-Barre syndrome, which can cause temporary paralysis, as a "very rare" side effect of the AstraZeneca Covid-19 vaccine. A causal relationship was "considered at least a reasonable possibility", the EMA said in an update Wednesday after a total of 833 cases...